294
Views
7
CrossRef citations to date
0
Altmetric
Efficacy of secukinumab on Psoriasis: evidences from real life experiences

Acrodermatitis continua of Hallopeau successfully treated with secukinumab

, , , &
Pages 3-5 | Received 24 Apr 2018, Accepted 27 Jul 2018, Published online: 21 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elia Rosi, Maria Thais Fastame, Antonella Di Cesare & Francesca Prignano. (2022) Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review. Expert Opinion on Biological Therapy 22:12, pages 1475-1487.
Read now
Austinn C. Miller, Timothy E. Holland & David J. Cohen. (2021) Treatment of acrodermatitis continua of hallopeau with ixekizumab. Journal of Dermatological Treatment 32:1, pages 117-119.
Read now
Mary Patricia Smith, Karen Ly, Quinn Thibodeaux, Tina Bhutani, Wilson Liao & Kristen M Beck. (2019) Acrodermatitis continua of Hallopeau: clinical perspectives. Psoriasis: Targets and Therapy 9, pages 65-72.
Read now
LM Smirnova, E Yu Vertieva, O Yu Olisova & EM Anpilogova. (2019) Outcomes of various types of therapy in patients with treatment-resistant acrodermatitis continua of Hallopeau. Biologics: Targets and Therapy 13, pages 83-87.
Read now

Articles from other publishers (3)

Katrina D Cirone & Fiona E Lovegrove. (2023) Acrodermatitis continua of Hallopeau successfully treated with bimekizumab: A case report. SAGE Open Medical Case Reports 11, pages 2050313X2311609.
Crossref
Christian Kromer, Emilia Loewe, Marthe‐Lisa Schaarschmidt, Andreas Pinter, Sascha Gerdes, Daniel Celis, Sietske Poortinga, Dagmar Wilsmann‐Theis & Rotraut Mössner. (2020) Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patients. The Journal of Dermatology 47:9, pages 989-997.
Crossref
Yuichi Kurihara, Kazuhisa Nakano, Ayaka Eto & Masutaka Furue. (2019) Successful treatment of acrodermatitis continua of Hallopeau with apremilast. The Journal of Dermatology 46:10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.